The Pharmacovigilance Practical Tools for Self-Assessment Second Edition is the definitive resource for pharmacovigilance professionals who must rapidly identify safety signal detection gaps, align global safety data sources, and ensure compliance with regulatory requirements under increasing scrutiny. Without a structured, auditable self-assessment framework, organisations risk undetected adverse event patterns, non-conformance findings during MHRA, FDA, or EMA inspections, delayed signal escalation, and reputational damage from compliance failures. This updated second edition delivers a comprehensive, ready-to-implement system that enables you to evaluate your pharmacovigilance programme’s maturity, benchmark against international standards, and produce defensible evidence of continuous improvement, transforming fragmented processes into a coordinated, inspection-ready safety surveillance function.
What You Receive
- 247 targeted self-assessment questions across six pharmacovigilance maturity domains (Signal Detection, Risk Management, Case Processing, Data Integration, Regulatory Reporting, and Quality Assurance), enabling you to pinpoint weaknesses in current practices and prioritise remediation efforts with precision
- 6 structured Excel scoring templates with automated calculations and visual dashboards that convert assessment responses into maturity scores, risk heat maps, and improvement priorities, saving hours of manual analysis and enabling clear communication with audit and compliance teams
- 65 practical implementation checklists and workflow templates in Word and Excel formats, covering signal validation workflows, PSUR/PBRER preparation timelines, aggregate report quality review steps, and audit trail maintenance, ensuring consistent, repeatable processes across your safety operations
- 10 real-world case study scenarios with model responses and recommended actions, illustrating how to apply the assessment framework to complex situations such as cross-border signal escalation, AI-based signal detection integration, and post-approval safety study oversight
- Complete alignment with ICH E2E, GVP Modules VI and IX, 21 CFR Part 11, and ISO 9001:2015 quality principles, providing a standards-based foundation for your assessments and ensuring compatibility with regulatory expectations during inspections
- Instant digital download access to all 214 pages of actionable content, including a master implementation roadmap, RACI matrices for pharmacovigilance activities, and a remediation tracking log, enabling deployment within one business week
How This Helps You
This self-assessment system transforms vague compliance concerns into targeted, evidence-based improvement plans. By systematically evaluating your signal detection protocols and adverse event processing workflows, you gain the ability to proactively address deficiencies before they result in regulatory citations or safety incidents. You’ll reduce audit preparation time by up to 50%, demonstrate compliance with GVP requirements through documented maturity assessments, and strengthen your pharmacovigilance governance framework with traceable decision records. The consequence of inaction is clear: reliance on ad hoc reviews increases the risk of missed signals, inconsistent reporting, and findings during regulatory audits, each carrying potential financial penalties, product suspension, or loss of market authorisation. With this toolkit, you establish a defensible, ongoing process for pharmacovigilance excellence that supports patient safety, regulatory confidence, and operational efficiency.
Who Is This For?
- Pharmacovigilance Managers and Drug Safety Officers responsible for maintaining compliant safety systems and preparing for regulatory audits
- Quality Assurance and Compliance Leads in biopharma and CROs who conduct internal safety audits and require standardised assessment criteria
- Regulatory Affairs Professionals seeking to validate pharmacovigilance components of marketing authorisation applications
- Project Leads implementing PV system upgrades or transitioning to new safety databases, needing gap analysis tools and remediation benchmarks
- Consultants and auditors delivering third-party PV assessments and requiring an industry-recognised evaluation framework
Choosing the Pharmacovigilance Practical Tools for Self-Assessment Second Edition is not just a purchase, it’s a strategic investment in regulatory resilience and patient safety leadership. You gain immediate access to a field-tested, standards-aligned system that empowers you to act with confidence, demonstrate compliance, and protect your organisation from avoidable risk. This is the professional standard for pharmacovigilance self-evaluation.
What does the Pharmacovigilance Practical Tools for Self-Assessment Second Edition include?
The Pharmacovigilance Practical Tools for Self-Assessment Second Edition includes 247 structured self-assessment questions across six pharmacovigilance maturity domains, 6 Excel-based scoring and dashboard templates, 65 implementation checklists and workflow tools in Word and Excel, 10 case study scenarios with model responses, and full alignment with ICH E2E, GVP Modules VI and IX, and 21 CFR Part 11 requirements. All materials are available as instant-download digital files, including a 214-page master guide, remediation tracking logs, and RACI matrices for safety processes.